Boston Scientific (BSX) Net Cash Flow Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 269.22% |
| 10 | Zimmer Biomet Holdings | 19.19 Bn | 18.78 Bn | 1.54 Bn | -45.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.83% |
| Mar 31, 2026 | -11.49% |
| Dec 31, 2025 | 2.24% |
| Sep 30, 2025 | 152.10% |
| Jun 30, 2025 | -39.71% |
| Mar 31, 2025 | 29.41% |
| Dec 31, 2024 | -510.91% |
| Sep 30, 2024 | 17.19% |
| Jun 30, 2024 | -4.26% |
| Mar 31, 2024 | 77.25% |
| Dec 31, 2023 | 34.86% |
| Sep 30, 2023 | 24.95% |
| Jun 30, 2023 | -28.17% |
| Mar 31, 2023 | -76.78% |
| Dec 31, 2022 | 113.38% |
| Sep 30, 2022 | 26.44% |
| Jun 30, 2022 | 2.86% |
| Mar 31, 2022 | -40.82% |
| Dec 31, 2021 | 27.23% |
| Sep 30, 2021 | -319.08% |